package industry

import (
	"log"
	"strings"

	"github.com/cfo/backend/internal/model"
)

// PharmaHandler provides industry-specific intelligence for pharmaceutical
// and healthcare companies. This includes drug manufacturers, biotech firms,
// medical device companies, and healthcare providers.
//
// TODO: Fully implement pharma-specific:
// - Intent resolution for pharma metrics (R&D spend, clinical trials, regulatory)
// - Data fetching from pharma-specific document chunks
// - Vocabulary expansion for pharmaceutical terminology
type PharmaHandler struct {
	// TODO: Add dependencies like storage, RAG service, etc.
}

// NewPharmaHandler creates a new pharmaceutical industry handler
func NewPharmaHandler() *PharmaHandler {
	return &PharmaHandler{}
}

// GetIndustryType returns the industry type this handler supports
func (h *PharmaHandler) GetIndustryType() model.IndustryType {
	return model.IndustryPharma
}

// ResolveIndustryIntent attempts to understand pharma-specific questions.
//
// Supported intents (TODO: implement fully):
// - rd_expenditure: Questions about R&D spending and investment
// - clinical_trials: Questions about trial costs, phases, progress
// - regulatory_costs: Questions about FDA/EMA approval costs
// - patent_status: Questions about patent expiry, IP portfolio
// - drug_revenue: Questions about revenue by drug/therapy
// - manufacturing_costs: Questions about production costs
// - market_access: Questions about pricing, reimbursement
// - pipeline_value: Questions about drug pipeline valuation
//
// TODO: Implement NLP-based intent matching or keyword extraction
func (h *PharmaHandler) ResolveIndustryIntent(question string) (industryIntent string, ok bool) {
	q := strings.ToLower(question)

	// TODO: Replace with proper NLP-based intent resolution
	// This is a simple keyword-based stub for demonstration

	pharmaKeywords := map[string]string{
		"r&d":           "rd_expenditure",
		"research":      "rd_expenditure",
		"development":   "rd_expenditure",
		"clinical":      "clinical_trials",
		"trial":         "clinical_trials",
		"phase":         "clinical_trials",
		"fda":           "regulatory_costs",
		"ema":           "regulatory_costs",
		"regulatory":    "regulatory_costs",
		"approval":      "regulatory_costs",
		"patent":        "patent_status",
		"ip":            "patent_status",
		"intellectual property": "patent_status",
		"drug":          "drug_revenue",
		"therapy":       "drug_revenue",
		"molecule":      "drug_revenue",
		"manufacturing": "manufacturing_costs",
		"production":    "manufacturing_costs",
		"cogs":          "manufacturing_costs",
		"pricing":       "market_access",
		"reimbursement": "market_access",
		"pipeline":      "pipeline_value",
		"candidate":     "pipeline_value",
		"indication":    "pipeline_value",
	}

	for keyword, intent := range pharmaKeywords {
		if strings.Contains(q, keyword) {
			log.Printf("[Pharma Handler] Resolved intent: %s for question containing '%s'", intent, keyword)
			return intent, true
		}
	}

	// No pharma-specific intent detected
	return "", false
}

// FetchIndustryData retrieves pharma-specific context chunks.
//
// TODO: Implement actual data fetching:
// 1. Query pharma-specific RAG storage (backend/data/rag/pharma/)
// 2. Filter by period if relevant
// 3. Score and rank chunks by relevance to intent
// 4. Return top K chunks for LLM context
func (h *PharmaHandler) FetchIndustryData(industryIntent string, period model.Period) (contextChunks []Chunk, err error) {
	log.Printf("[Pharma Handler] FetchIndustryData called for intent: %s, period: %s to %s",
		industryIntent, period.Start, period.End)

	// TODO: Implement actual data fetching from pharma RAG storage
	// For now, return empty chunks - the system will fall back to generic logic

	// Placeholder: Return sample context based on intent
	switch industryIntent {
	case "rd_expenditure":
		// TODO: Fetch actual R&D data from parsed pharma documents
		contextChunks = []Chunk{
			{
				Text:   "/* TODO: Fetch R&D expenditure data from pharma RAG */",
				Source: "pharma_rag",
				Metadata: map[string]interface{}{
					"intent": industryIntent,
					"type":   "placeholder",
				},
			},
		}
	case "clinical_trials":
		// TODO: Fetch clinical trial data
		contextChunks = []Chunk{
			{
				Text:   "/* TODO: Fetch clinical trial data from pharma RAG */",
				Source: "pharma_rag",
				Metadata: map[string]interface{}{
					"intent": industryIntent,
					"type":   "placeholder",
				},
			},
		}
	case "pipeline_value":
		// TODO: Fetch drug pipeline data
		contextChunks = []Chunk{
			{
				Text:   "/* TODO: Fetch pipeline value data from pharma RAG */",
				Source: "pharma_rag",
				Metadata: map[string]interface{}{
					"intent": industryIntent,
					"type":   "placeholder",
				},
			},
		}
	default:
		// No specific data for this intent yet
		contextChunks = []Chunk{}
	}

	return contextChunks, nil
}

// GetIndustryVocabulary returns pharma-specific terminology.
// These terms help the LLM understand pharmaceutical jargon and provide better responses.
func (h *PharmaHandler) GetIndustryVocabulary() []string {
	return []string{
		// R&D metrics
		"R&D Expenditure: Total spending on research and development activities",
		"R&D Intensity: R&D spend as percentage of revenue (pharma avg: 15-25%)",
		"Pipeline Value: Estimated future value of drugs in development",
		"Cost Per NME (New Molecular Entity): Total cost to develop a new drug (~$2-3B avg)",

		// Clinical trial terms
		"Phase I: Initial safety testing in healthy volunteers (20-100 people)",
		"Phase II: Efficacy and dosing studies in patients (100-500 people)",
		"Phase III: Large-scale efficacy trials for regulatory approval (1000-5000 people)",
		"Phase IV: Post-market surveillance and real-world evidence",
		"Clinical Trial Cost: Average costs escalate from ~$10M (Phase I) to ~$300M+ (Phase III)",

		// Regulatory terms
		"NDA (New Drug Application): FDA submission for new drug approval",
		"BLA (Biologics License Application): FDA submission for biologic drugs",
		"PDUFA (Prescription Drug User Fee Act): FDA review timeline framework",
		"EMA (European Medicines Agency): European regulatory authority",
		"Priority Review: Expedited FDA review for important drugs (6 months vs 10)",

		// Revenue and IP terms
		"Patent Cliff: Revenue decline when key patents expire",
		"Exclusivity Period: Time period of market exclusivity before generics (typically 5-12 years)",
		"Biobucks: Milestone-based payments in licensing deals",
		"Royalty Rate: Percentage of sales paid to IP licensor (pharma avg: 3-10%)",

		// Manufacturing terms
		"COGS (Cost of Goods Sold): Direct manufacturing costs for drugs",
		"Gross Margin: Pharma typically has high gross margins (70-90%)",
		"API (Active Pharmaceutical Ingredient): The active drug compound",
		"GMP (Good Manufacturing Practice): Quality standards for drug production",

		// TODO: Add more pharma-specific vocabulary as needed
	}
}

